INTERCREDITOR AGREEMENTIntercreditor Agreement • April 1st, 2013 • Biozone Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 1st, 2013 Company IndustryThis INTERCREDITOR AGREEMENT, dated as of March ___, 2013 (this “Agreement”), is among _______________ (the “Subordinating Creditor”), BioZone Pharmaceuticals, Inc. (the “Debtor”) and MIDLAND AMERICAN CAPITAL CORPORATION (the “Senior Creditor”).
PURCHASE MONEY FINANCING RIDERPurchase Money Financing Rider • April 1st, 2013 • Biozone Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 1st, 2013 Company IndustryThis PURCHASE MONEY FINANCING RIDER (“Rider”) is dated as of March ____, 2013 between BioZone Laboratories, Inc., a California corporation (“Debtor”) and Midland American Capital Corporation, a Nevada corporation (“Secured Party”).
March ____, 2013Biozone Pharmaceuticals, Inc. • April 1st, 2013 • Pharmaceutical preparations
Company FiledApril 1st, 2013 IndustryReference is hereby made to that certain Factoring and Security Agreement (“the Factoring Agreement”), dated as of an approximately even date herewith, by and among Seller and Midland American Capital Corporation. All capitalized terms not otherwise defined herein shall have the meaning ascribed to such term in the Factoring Agreement.
GUARANTY AND SECURITY AGREEMENT THIS DOCUMENT CONTAINS A WAIVER OF TRIAL BY JURYGuaranty and Security Agreement • April 1st, 2013 • Biozone Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 1st, 2013 Company IndustryThis GUARANTY AND SECURITY AGREEMENT dated as of March ___, 2013, is made by the entities or individuals which have signed below (individually or collectively, “Guarantor”), in favor of Midland American Capital Corporation, a Nevada Corporation (“Creditor”).
FACTORING AND SECURITY AGREEMENTFactoring and Security Agreement • April 1st, 2013 • Biozone Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 1st, 2013 Company IndustryTHIS FACTORING AND SECURITY AGREEMENT is made as of March 22, 2013 by and between BioZone Laboratories, Inc., a California corporation (“Seller”) and Midland American Capital Corporation, a Nevada corporation (“Purchaser”).